Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 106, Issue 19
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Cardiac risk factors and prevention
Original research
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
Online download statistics by month:
Online download statistics by month: July 2020 to May 2021
Abstract
Full
Pdf
Jul 2020
4831
4772
952
Aug 2020
846
841
147
Sep 2020
839
825
217
Oct 2020
484
424
188
Nov 2020
356
272
149
Dec 2020
274
220
116
Jan 2021
289
205
106
Feb 2021
272
215
118
Mar 2021
327
265
120
Apr 2021
302
235
88
May 2021
231
189
74
Total
9051
8463
2275
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF